Sign In
Buy CNSP
$5.24
+0.320 (+6.50%)
At Close: Jun 03, 2026
Le ministre-président wallon prendra le pouls des députés wallons quant à un approfondissements des négociations fédérales, et d'une possible coalition avec la N-VA.
Légalement, les camps scouts ne peuvent pas compter plus de 50 participants: "On n'est pas encore de retour à la vie normale"
10:50pm, Wednesday, 10'th Jun 2020
Mais pour le Dr Van Laethem, “c’est un ordre de grandeur”
La limite de 50 participants pour les camps scouts cet été ne sera pas relevée
03:43pm, Wednesday, 10'th Jun 2020
Le ministre-président de la Fédération Wallonie-Bruxelles, Pierre-Yves Jeholet (MR), a exclu mercredi de plaider lors d'un prochain Conseil national de sécurité (CNS) pour un relèvement du plafo
Inovio Pharmaceuticals: Positioning For A Global Opportunity (NASDAQ:INO)
01:36am, Wednesday, 10'th Jun 2020
External funding sources and partnerships are developing into a long-term strategic opportunity for Inovio. Accelerating COVID vaccine testing is an urgent worl
CNS Announces Highlights from Annual Meeting of Shareholders
12:00pm, Tuesday, 09'th Jun 2020
CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and
Autobahn Therapeutics Launches with $76 Million Series B Financing to Develop Next Generation Therapies for CNS Disorders
12:00am, Tuesday, 09'th Jun 2020
Autobahn Therapeutics Launches with $76 Million Series B Financing to Develop Next Generation Therapies for CNS Disorders
Neurana Pharmaceuticals Announces First Patient Enrolled in CNS Effects Clinical Study
06:06pm, Monday, 08'th Jun 2020
SAN DIEGO, June 8, 2020 /PRNewswire via COMTEX/ --
SAN DIEGO, June 8, 2020 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical...
The first Catholic bishop to take the knee at a Black Lives Matter rally got a call from Pope Francis
05:56pm, Thursday, 04'th Jun 2020
Pope Francis reached out this week to El Paso, Texas, Bishop Mark J. Seitz, the first Catholic bishop to publicly take the knee in symbolic recognition of racial injustice and police brutality in Amer
Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Ne
'Neurological symptoms of coronavirus infection decoded'
09:45am, Sunday, 31'st May 2020
Read more about 'Neurological symptoms of coronavirus infection decoded' on Devdiscourse
Clinical trial shows promising new treatment for rare blood cancer
03:29am, Sunday, 31'st May 2020
Scientists have found that chemotherapy combined with drug "rituximab" coupled with treatment for the secondary Central Nervous System (CNS) problem, shows promising results for patients suffering fro
2020 Global Central Nervous System Disorders Pipeline Database - ResearchAndMarkets.com
07:28am, Friday, 29'th May 2020
The "Central Nervous System Disorders Pipeline Database - 2020" report has been added to ResearchAndMarkets.com's offering. This database provides the most...
2020 Global Central Nervous System Disorders Pipeline Database - ResearchAndMarkets.com
12:00am, Friday, 29'th May 2020
The
CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies
12:00pm, Thursday, 28'th May 2020
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and c
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
10:00pm, Wednesday, 27'th May 2020
CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and
